Actuate Therapeutics Statistics
Total Valuation
ACTU has a market cap or net worth of $154.30 million. The enterprise value is $145.66 million.
| Market Cap | 154.30M |
| Enterprise Value | 145.66M |
Important Dates
The next estimated earnings date is Wednesday, May 21, 2025, before market open.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACTU has 19.53 million shares outstanding. The number of shares has increased by 483.48% in one year.
| Current Share Class | 19.53M |
| Shares Outstanding | 19.53M |
| Shares Change (YoY) | +483.48% |
| Shares Change (QoQ) | +81.47% |
| Owned by Insiders (%) | 4.90% |
| Owned by Institutions (%) | 1.14% |
| Float | 5.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1,481.00 |
| P/TBV Ratio | 1,481.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05
| Current Ratio | 1.05 |
| Quick Ratio | 0.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,344.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -255.41% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -4,876.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.73M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 8.04 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 55.25 |
| Average Volume (20 Days) | 37,339 |
Short Selling Information
The latest short interest is 84,504, so 0.43% of the outstanding shares have been sold short.
| Short Interest | 84,504 |
| Short Previous Month | 77,351 |
| Short % of Shares Out | 0.43% |
| Short % of Float | 1.42% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.16M |
| Pretax Income | -27.77M |
| Net Income | -27.29M |
| EBITDA | n/a |
| EBIT | -25.16M |
| Earnings Per Share (EPS) | -$3.26 |
Balance Sheet
The company has $8.64 million in cash and n/a in debt, giving a net cash position of $8.64 million or $0.44 per share.
| Cash & Cash Equivalents | 8.64M |
| Total Debt | n/a |
| Net Cash | 8.64M |
| Net Cash Per Share | $0.44 |
| Equity (Book Value) | 104,186 |
| Book Value Per Share | 0.01 |
| Working Capital | 405,397 |
Cash Flow
| Operating Cash Flow | -21.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACTU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -483.48% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.68% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ACTU is $20.00, which is 153.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 153.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |